Description

tert-Butyl 6-Oxo-5-Oxa-2,7-Diazaspiro[3.4]Octane-2-Carboxylate CAS NO 1799438-98-4 is a high-purity, advanced pharmaceutical intermediate featuring a unique spirocyclic scaffold. This compound is of significant value for medicinal chemistry research and development, serving as a critical building block for constructing novel bioactive molecules. It is primarily sought after by pharmaceutical R&D teams and fine chemical manufacturers engaged in the synthesis of new drug candidates, particularly in areas targeting central nervous system (CNS) disorders and other therapeutic applications.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel active pharmaceutical ingredients (APIs) with potential neurological activity.
• Medicinal Chemistry Research: Used as a versatile scaffold for constructing compound libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• Proteolysis Targeting Chimera (PROTAC) Development: Serves as a potential linker or component in the design of heterobifunctional molecules for targeted protein degradation.
• CNS Drug Discovery: Employed in the research and development of therapeutics for conditions such as depression, anxiety, and neurodegenerative diseases.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for fundamental studies in organic synthesis and bioorganic chemistry.

Basic Information

Product Name	tert-Butyl 6-Oxo-5-Oxa-2,7-Diazaspiro[3.4]Octane-2-Carboxylate
CAS No.	1799438-98-4
Molecular Formula	C11H18N2O4
Molecular Weight	242.27 g/mol
Synonyms	2,7-Diazaspiro[3.4]octane-2-carboxylic acid, 6-oxo-5-oxa-, 1,1-dimethylethyl ester; 1,1-Dimethylethyl 6-oxo-5-oxa-2,7-diazaspiro[3.4]octane-2-carboxylate; tert-Butyl 6-oxo-5-oxa-2,7-diazaspiro[3.4]octane-2-carboxylate; 2,7-Diazaspiro[3.4]octane-2-carboxylic acid, 6-oxo-5-oxa-, tert-butyl ester; Spirocyclic Oxazolidinone Ester; Boc-Protected Diazaspirooctane Derivative
EINECS	Contact for details

Quality Control

Our production of tert-Butyl 6-Oxo-5-Oxa-2,7-Diazaspiro[3.4]Octane-2-Carboxylate adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to confirm identity and purity. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes. We support our clients' regulatory needs with traceable documentation suitable for use in cGMP-compliant environments.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to minimize exposure to moisture. Store away from incompatible materials such as strong acids and organic solvents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.